Antitumor activity of novel POLA1-HDAC11 dual inhibitors.

MLA

Dallavalle, Sabrina, et al. “Antitumor Activity of Novel POLA1-HDAC11 Dual Inhibitors.” European Journal of Medicinal Chemistry, vol. 228, Jan. 2022, p. 113971. EBSCOhost, https://doi.org/10.1016/j.ejmech.2021.113971.

APA

Dallavalle, S., Musso, L., Cincinelli, R., Darwiche, N., Gervasoni, S., Vistoli, G., Guglielmi, M. B., La Porta, I., Pizzulo, M., Modica, E., Prosperi, F., Signorino, G., Colelli, F., Cardile, F., Fucci, A., D’Andrea, E. L., Riccio, A., & Pisano, C. (2022). Antitumor activity of novel POLA1-HDAC11 dual inhibitors. European Journal of Medicinal Chemistry, 228, 113971. https://doi.org/10.1016/j.ejmech.2021.113971

Chicago

Dallavalle, Sabrina, Loana Musso, Raffaella Cincinelli, Nadine Darwiche, Silvia Gervasoni, Giulio Vistoli, Mario B Guglielmi, et al. 2022. “Antitumor Activity of Novel POLA1-HDAC11 Dual Inhibitors.” European Journal of Medicinal Chemistry 228 (January): 113971. doi:10.1016/j.ejmech.2021.113971.